Signaling pathways
-
BA6970 PF-06305591Summary: PF-06305591 is a potent and highly selective blocker of voltage-gated sodium channels. - BA6971 PF-06869206Summary: PF-06869206 is an effective.
- BA6972 GDC-0310Summary: GDC-0310 is a selective acylsulfonamide inhibitor.
- BA6973 FunapideSummary: An effective inhibitor.
- BA6974 DSP-2230Summary: Selective channel blockers.
- BA6975 EvenamideSummary: Evenamide (NW-3509), a potent, orally active voltage-gated sodium channel blocker.
- BA6976 RalfinamideSummary: Ralfinamide (FCE-26742A) is an orally available, alpha-aminoamide-derived blocker
- BA6977 SLC13A5-IN-1Summary: SLC13A5-IN-1 is a selective sodium citrate cotransporter protein inhibitor.
- BA6978 S3969Summary: S3969 is a potent and reversible human epithelial sodium channel activator.
- BA6979 RY796Summary: RY796 is a potent and selective inhibitor with values of 0.25 μM and 0.09 μM for K2.1 and K2.2, respectively.